Invesco
MBII

Invesco’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Invesco’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-33,949
Closed -$37K – 4215
2022
Q1 		$37K Sell
33,949
-791
-2% -$597 ﹤0.01% 3953
2021
Q4 		$25K Sell
34,740
-1,066
-3% -$862 ﹤0.01% 4018
2021
Q3 		$32K Buy
35,806
+8,973
+33% +$10.8K ﹤0.01% 4011
2021
Q2 		$45K Sell
26,833
-24,712
-48% -$41.3K ﹤0.01% 3954
2021
Q1 		$108K Buy
51,545
+2,059
+4% +$4.28K ﹤0.01% 3752
2020
Q4 		$62K Buy
+49,486
New +$59K ﹤0.01% 3718
2019
Q1 		– Sell
-19,047
Closed -$28K – 3876
2018
Q4 		$28K Sell
19,047
-17,798
-48% -$27.3K ﹤0.01% 3742
2018
Q3 		$67K Buy
36,845
+1,697
+5% +$3.29K ﹤0.01% 3808
2018
Q2 		$65K Buy
+35,148
New +$65.4K ﹤0.01% 3793

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
EFI
EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

Invesco's MBII Position: Q2 2022 in Review

Invesco sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2022, closing a stake of 33,949 shares — an estimated $37K sold.

Invesco first reported a position in MBII in Q2 2018 and held it in 9 quarters. The position peaked at $108K in Q1 2021. 62 funds tracked by Wall St. Rank hold MBII as of Q2 2022.

  • Invesco reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 33,949 Marrone Bio Innovations, Inc. shares in Q2 2022, an estimated $37K.
  • Invesco first reported a position in Marrone Bio Innovations, Inc. in Q2 2018 and held it in 9 quarters.
  • Invesco's Marrone Bio Innovations, Inc. position peaked at $108K in Q1 2021.
  • 62 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.